Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

unknown1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
active_not_recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation

NCT04681872
completednot_applicable

MARSHALL PLAN Vs. Pulmonary Veins Isolation Monocentric Trial

NCT04206982
unknownnot_applicable

Individualised Mapping in Persistent AF Ablation

NCT05065112

Clinical Trials (3)

Showing 3 of 3 trials
NCT04681872Not Applicable

Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation

Active Not Recruiting
NCT04206982Not Applicable

MARSHALL PLAN Vs. Pulmonary Veins Isolation Monocentric Trial

Completed
NCT05065112Not Applicable

Individualised Mapping in Persistent AF Ablation

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3